Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer - Part B: Volume 399, (9780443414138) — Readings Books

Become a Readings Member to make your shopping experience even easier. Sign in or sign up for free!

Become a Readings Member. Sign in or sign up for free!

Hello Readings Member! Go to the member centre to view your orders, change your details, or view your lists, or sign out.

Hello Readings Member! Go to the member centre or sign out.

Cart ⚙️
Home / Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer - Part B: Volume 399
 
Hardback

Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer - Part B: Volume 399

$938.99
Add to wishlist
Sign in or become a Readings Member to add this title to your wishlist.

Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer Patients, Part B delves into the crucial role of circulating biomarkers in cancer diagnosis and treatment monitoring. Specific chapters in this new release include Liquid biopsy approaches to capture minimal residual disease and therapy response in patients with early stage cancers, Identification of circulating biomarkers for cancer therapy-related cardiovascular toxicity, Extracellular Vesicles as Dynamic Biomarkers: Monitoring Therapeutic Responses and Drug Resistance in Cancer, and more.

This comprehensive work explores the various types of biomarkers, their significance in early cancer detection, prognostication, and evaluation of therapeutic responses. It covers cutting-edge research on circulating tumor cells, cell-free DNA, exosomes, and other biomarkers that can revolutionize cancer management. Additionally, it discusses the challenges, advancements, and future prospects of utilizing circulating biomarkers in personalized cancer care.

Read More
In Shop
Out of stock
Shipping & Delivery

$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout

MORE INFO

Stock availability can be subject to change without notice. We recommend calling the shop or contacting our online team to check availability of low stock items. Please see our Shopping Online page for more details.

Format
Hardback
Publisher
Elsevier Science Publishing Co Inc
Country
United States
Date
1 March 2026
Pages
277
ISBN
9780443414138

Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer Patients, Part B delves into the crucial role of circulating biomarkers in cancer diagnosis and treatment monitoring. Specific chapters in this new release include Liquid biopsy approaches to capture minimal residual disease and therapy response in patients with early stage cancers, Identification of circulating biomarkers for cancer therapy-related cardiovascular toxicity, Extracellular Vesicles as Dynamic Biomarkers: Monitoring Therapeutic Responses and Drug Resistance in Cancer, and more.

This comprehensive work explores the various types of biomarkers, their significance in early cancer detection, prognostication, and evaluation of therapeutic responses. It covers cutting-edge research on circulating tumor cells, cell-free DNA, exosomes, and other biomarkers that can revolutionize cancer management. Additionally, it discusses the challenges, advancements, and future prospects of utilizing circulating biomarkers in personalized cancer care.

Read More
Format
Hardback
Publisher
Elsevier Science Publishing Co Inc
Country
United States
Date
1 March 2026
Pages
277
ISBN
9780443414138

Looking for something in particular?

Search our extensive online catalogue.